HOME >> BIOLOGY >> NEWS
Early treatment can prevent severe vision loss in premature infants

A new study by specialists at the Johns Hopkins Children's Center and 25 other institutions nationwide for the first time gives eye doctors a precise way to identify premature babies at the highest risk of abnormal blood vessel growth in the retina and subsequent blindness. The computerized risk assessment tool they used should lead to treatment of retinopathy of prematurity (ROP) at its earliest stages, stopping or limiting both loss of vision and structural damage to the eye.

"Before this study, we did not have a precise clinical model to follow to help predict which infants will ultimately develop vision loss from ROP, so we often had to defer treatment until the disease reached the treatment 'threshold,' at which point there was still a 25 percent chance of retinal detachment," says Michael Repka, M.D., a pediatric ophthalmologist at the Children's Center, and a member of the study team. "Unfortunately, delaying therapy to that point leaves some infants with vision loss."

Using both old and new criteria, researchers were able to identify which premature infants enrolled in the study were at highest risk for blindness. Results of their study, published in the December issue of the Archives of Ophthalmology, show that early treatment significantly reduced the likelihood of poor vision from 19.5 to 14.5 percent at about one year of age. Early treatment also reduced the likelihood of structural damage to the eye from 15.6 to 9.1 percent.

According to Repka, ROP presents ophthalmologists with difficult treatment decisions because the disease can be highly unpredictable. In many infants, he says, it can spontaneously improve and spare the child's vision, while in others, it can suddenly progress and result in blindness.

For the study, the researchers identified 499 out of 828 infants diagnosed at birth with ROP as being at higher than usual risk for vision loss, based on the computerized guide that assessed birth weight, ethnicity,
'"/>

Contact: Jessica Collins
jcolli31@jhmi.edu
410-516-4570
Johns Hopkins Medical Institutions
8-Dec-2003


Page: 1 2

Related biology news :

1. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
2. Early detection hope for eye disease
3. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
4. Early dexamethasone exposure has long-term neurodevelopment, neuroendocrine effects
5. Early predictor of breast cancer aggressiveness
6. Early treatment confirmed as key to stroke recovery
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Early promise for treatment of Ebola
9. Early hominids may have behaved more human than we had thought
10. Early infection and rejection detection
11. Early-life environments shape development of stress behaviors and learning abilities in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... N.Y. (PRWEB) , ... August 13, 2018 , ... ... new 2017/18 products, the Staticmaster® P-2021-5502 and P-2021-5602 Cleanroom Ionizing Gun. , ... VTE-208 Filtered Nitrogen Air Gun, P-2021 ionizing cartridge, 0.5-micron filter and electropolished OSHA-compliant ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... solutions for the global scientific community, announced today the establishment of a new ... division is to foster and support scientific collaborations with ActiGraph’s academic and pharmaceutical ...
(Date:8/14/2018)... ... August 14, 2018 , ... From reconstruction of craniofacial syndrome ... better understanding of congenital heart defects, 3-D printing is providing exciting approaches to ... of Birth Defects Research (DOI: 10.1002/bdr2.1367). , The special ...
Breaking Biology News(10 mins):
(Date:7/27/2018)... ... July 27, 2018 , ... ... of the Biotechnology Innovation Organization (BIO) met with U.S. Environmental Protection Agency ... a Toxic Substances Control Act (TSCA) Inventory Representation and Equivalency Determinations for ...
(Date:7/25/2018)... ... July 25, 2018 , ... Vium, Inc. http://www.vium.com ... and Vium Cloud approach to accelerate preclinical drug discovery and development, today announced ... announced the appointment of Jeff Caron to the newly formed role of Senior ...
(Date:7/24/2018)... ... July 23, 2018 , ... ... energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune function responses. ... assessed in the preclinical research were significantly reduced. Results are as follows:, ...
(Date:7/22/2018)... ... July 19, 2018 , ... CallTower ... joined their team. With more than ten years of strategic, result-oriented Channel experience ... expertise as CallTower’s Channel Director for the Southwest and Mountain region. , As ...
Breaking Biology Technology:
Cached News: